SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002604
Filing Date
2023-02-15
Accepted
2023-02-15 16:30:45
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02152023_040213.html 4  
1 form4-02152023_040213.xml 4 3526
  Complete submission text file 0001415889-23-002604.txt   4879
Mailing Address C/O APPLIED GENETIC TECHNOLOGIES CORP 11801 RESEARCH DRIVE, SUITE D ALACHUA FL 32615
Business Address
Shearman Mark S (Reporting) CIK: 0001643799 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 23635782

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)